PedAM
Pediatric Disease Annotations & Medicines
| Disease | liver cirrhosis |
| Phenotype | |hypertension |
| Sentences | 72 |
| PubMedID- 22916658 | Portal hypertension and varices in patients with liver cirrhosis. |
| PubMedID- 23547461 | [the protective effect of n-acetylcysteine magnesium against liver cirrhosis with portal hypertension in rat]. |
| PubMedID- 22878372 | This is due to the common practice of intermittent clamping of drains, because of a perceived risk of hypotension with free drainage, based on historical experience with paracentesis for transudative ascites due to hypo-albuminaemia and portal hypertension in patients with liver cirrhosis. |
| PubMedID- 25499848 | Portal hypertensive gastropathy (ghp) is a complication of portal hypertension usually associated with liver cirrhosis. |
| PubMedID- 23855493 | Impaired endothelial function is a major cause of portal hypertension in liver cirrhosis. |
| PubMedID- 23729979 | Portal vein interventions in liver transplant recipients represent a group of interventions in the management of several disease entities including portal vein stenosis, portal vein thrombosis, and recurrent liver cirrhosis with portal hypertension with and without gastric varices. |
| PubMedID- 24960036 | Objective: to investigate the effects and technical points of laparoscopic splenectomy and esophagogastric devascularization (ls+ed) for portal hypertension (ph) due to liver cirrhosis. |
| PubMedID- 26091449 | Esophageal varix is one of the serious complications of liver cirrhosis resulting from portal hypertension.1 given the high prevalence of varices and the significant mortality rate associated with variceal hemorrhage, early diagnosis of clinically significant portal hypertension (≥10 mm hg) and varices is of paramount importance in the management of compensated cirrhosis and in the prevention of liver-related morbidity and mortality. |
| PubMedID- 25061484 | Portal hypertension in the course of liver cirrhosis is the cause of serious complications, including ascites, hepatic encephalopathy and bleeding from oesophageal varices. |
| PubMedID- 26370856 | Hypothyroidism enhanced portal hypertension in a patient with alcoholic liver cirrhosis, resulting in the development of ascites. |
| PubMedID- 21705304 | A detailed interview and examination by occupational health and other medical specialists revealed that the patient had been suffering from wilson's disease from the age of 13, and had now developed hepatic manifestations (compensated liver cirrhosis with portal hypertension), neurological manifestations (dystonia, dysarthria, muscle weakness, vertigo), and psychiatric manifestations (depression, insomnia, cognitive impairment) of the disease, including problems partially caused by long-lasting treatment with copper chelating agents (neurological and haematological manifestations). |
| PubMedID- 24949616 | Partial splenic embolization is an effective interventional procedure performed in liver cirrhosis complicated with portal hypertension to improve the low platelet count. |
| PubMedID- 24820919 | Case background: ascites appears mainly as a consequence of portal hypertension in patients with liver cirrhosis, or can be caused by several other causes, such us congestive heart failure, peritoneal malignancy, or tuberculosis. |
| PubMedID- 20534306 | The transjugular intrahepatic portosystemic shunt (tips) is an acceptable procedure that has proven benefits in the treatment of patients who have complications from portal hypertension due to liver cirrhosis. |
| PubMedID- 24963938 | Patients with hcc are predisposed to upper gi haemorrhage as they commonly have portal hypertension either due to underlying liver cirrhosis or due to portal vein involvement by tumour thrombus. |
| PubMedID- 21802316 | Purpose: to develop a clinically relevant porcine model of liver cirrhosis with portal hypertension by means of hepatic transarterial embolization. |
| PubMedID- 26516439 | The american association for the study of liver diseases (aasld) and the european association for the study of the liver (easl) have established guidelines that indicate that liver cirrhosis with portal hypertension is a relative contraindication for hepatic resection because of the high risk liver failure after the operation (14–17). |
| PubMedID- 21577041 | The main cause of gastroesophageal variceal bleeding (gevb) is portal hypertension (ph) due to liver cirrhosis. |
| PubMedID- 24914368 | Selection of a tips stent for management of portal hypertension in liver cirrhosis: an evidence-based review. |
| PubMedID- 21460144 | Methods: spectral doppler sonography of the hepatic vein was performed on 22 consecutive patients who underwent hvpg measurement for portal hypertension with liver cirrhosis. |
| PubMedID- 26378453 | Portal hypertension may develop in patients with liver cirrhosis, as a result of an increased intrahepatic vascular resistance, reduced systemic vascular resistance and increased portal inflow. |
| PubMedID- 23743385 | However, an increase in splenic blood flow may play a role in the development of saa in patients with portal hypertension due to liver cirrhosis or transplantation. |
Page: 1 2